The Serology Working Group provides oversight of sero-epidemiology work for COVID-19 in England and partners with international colleagues, including the WHO, on these serological studies. The group monitors and reviews work on the establishment and running of population-based seroprevalence surveys in England. Sero-epidemiology is crucial in informing our understanding of the extent of transmission of SARS-CoV-2, and to monitor how this changes over time.
The Serology Working Group was disbanded in April 2020. The group’s work is now part of PHE’s surveillance programme for COVID-19.
| Dr Gayatri Amirthalingam | Public Health England (PHE) |
| Dr Marc Baguelin | London School of Hygiene and Tropical Medicine |
| Professor Wendy Barclay | Imperial College London |
| Dr Rupert Beale | Francis Crick Institute |
| Dr Tim Brooks | Public Health England (PHE) |
| Dr Mary De Silva | Wellcome Trust |
| Professor Sir Jeremy Farrar | Wellcome Trust |
| Professor Paul Kellam | Imperial College London and Kymab Ltd |
| Professor Sharon Peacock | Public Health England (PHE) |
| Dr Mary Ramsay | Public Health England (PHE) |
| Professor Gavin Screaton | University of Oxford |
| Dr Edwin Van Leeuwen | Public Health England (PHE) |
5 participants have not given permission to be named.
Saving...